GTR 119608701
Bids Are Invited For Agreement For The Supply Of Rituximab Biosimilar Injectable Solution For The Hospital Del Salvador
ICB — International Competitive Bid
Closes Nov 09, 2026
South America
Tender Information
GTR Reference
119608701
Tendering Authority
Subscribe to view
Tender No
1058085-153-LP26
Financer Name
Self-Funded
Work Title
Bids Are Invited For Agreement For The Supply Of Rituximab Biosimilar Injectable Solution For The Hospital Del Salvador
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
South America
Political Region
Asia-Pacific Economic Cooperation, APEC,APAC (Asia Pacific)
Last Date of Bid Submission
09-11-2026
Work Detail
That, The Hospital Del Salvador Needs To Have An Agreement For The Supply Of Rituximab Biosimilar Injectable Solution For The Hospital Del Salvador In Order To Adequately And Efficiently Satisfy The Care Work During The Period Of 36 Months;That, The Medicine Rituximab Corresponds To A Monoclonal Antibody Of Biological Origin, Whose Complexity Can Generate Differences Inherent To The Manufacturing Processes, Which Requires Considering Aspects Associated With Immunogenicity, Safety, Efficacy And Traceability, Being Subject To The Provisions Of Technical Standard No. 170, Which Establishes Criteria For The Evaluation Of Biosimilarity And Interchangeability.That, Two Biosimilar Products Of Rituximab Are Available On The Market And Have Demonstrated Biosimilarity With Respect To The Reference Product. Notwithstanding This, They Correspond To Biological Products Developed And Manufactured Independently, So Their Use Must Consider The Available Information Regarding Safety, Efficacy And Immunogenicity That May Cause Changing Manufacturers.That, The Hospital Del Salvador Currently Has Patients Being Treated With Certain Presentations Of Rituximab, So It Is Necessary To Safeguard The Continuity Of The Therapies Started, Maintaining The Product With Which The Treatment Has Been Started, In Accordance With Current Regulations And The Available Safety And Efficacy Records.That, By Virtue Of The Above, The Hospital Del Salvador Requires To Have Two Alternatives For Rituximab Injectable Solution, In Order To Ensure The Continuity Of The Treatments Of Patients Currently Undergoing Therapy And, In Turn, To Have An Alternative For Patients Who Begin Treatment, Avoiding Unnecessary Changes During Therapies Already Established And Safeguarding The Continuity, Traceability And Safety Of The Treatments.That, For The Determined Amount, This Tender Is Located In The Section For Contracts Equal To Or Greater Than 1,000 Utm And Less Than 5,000 Utm, In Accordance With Article 40 Of The Regulations Of Law No. 19,886;That, After Making The Respective Queries, The Provision Of These Goods Or Services Is Not Available Through Framework Agreements Offered In The Information System Of The Purchasing Directorate, Www.Mercadopublico.Cl;That, This Purchase Is Linked To Projects 1058085-10-Pc26 Of The Annual Purchase Plan For The Year 2026.
Key Value
Tender Value
107,968,630 - CLP
Tender Documents
Global Tender Document
228b0416-d453-4c71-8970-d11f3360adda.html
Attachments
Additional Details Available on Click
- Tendering Authority
- Publication Document (Tender Document / Tender Notice)
Disclaimer
We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.